An off-label prescription is when a doctor prescribes an FDA-approved medication for a purpose, dose, or form that the FDA hasn’t specifically approved. The drug itself is legal and regulated, but it’s being used in a way that wasn’t part of the original approval. This is surprisingly common: roughly 1 in 4 prescriptions in the United States are written for off-label uses.
What Counts as Off-Label Use
The FDA defines off-label use in three ways. A drug can be prescribed for a condition it wasn’t approved to treat, such as a cancer drug approved for one type of cancer being used for a different type. It can be given in a different form, like receiving an oral solution instead of the approved capsule. Or it can be prescribed at a different dose than what the label specifies.
What off-label does not mean is experimental or untested. Many off-label uses have years of clinical evidence behind them and are widely accepted in medical practice. The gap between what a drug is approved for and what it actually works for exists largely because FDA approval is expensive and time-consuming. Drug manufacturers often don’t pursue approval for every condition a medication can treat, especially if the drug is already available as a generic and there’s no financial incentive to run new trials.
Why Doctors Prescribe This Way
Once the FDA approves a drug, doctors are legally permitted to prescribe it for any use they judge medically appropriate. This isn’t a loophole. It’s a recognized part of how medicine works, and the FDA explicitly acknowledges it. Physicians rely on published research, clinical guidelines, and their own experience to decide when an off-label use makes sense for a specific patient.
In some areas of medicine, off-label prescribing is the norm rather than the exception. In pediatric care, between 36% and 47% of medications prescribed in the U.S. are for off-label uses, largely because many drugs were only tested in adults during their approval process. Children still need treatment, and doctors use the best available evidence to guide those decisions.
Common Examples
Off-label prescribing spans nearly every medical specialty. Some of the most familiar examples include:
- Beta-blockers for performance anxiety. These heart and blood pressure medications are frequently prescribed for social phobia and public speaking anxiety because they block the physical symptoms of a stress response, like a racing heart and shaky hands.
- Trazodone for insomnia. Approved as an antidepressant, trazodone is one of the most commonly prescribed sleep aids, particularly for older adults.
- Gabapentin for nerve pain. Originally approved for seizures, gabapentin is widely used for conditions like fibromyalgia, diabetic nerve pain, restless leg syndrome, and hot flashes.
- Tricyclic antidepressants for chronic pain. Older antidepressants are frequently prescribed at lower doses for nerve pain, irritable bowel syndrome, and insomnia.
- Antipsychotics for anxiety and PTSD. Newer antipsychotic medications are used off-label for anxiety disorders, eating disorders, and post-traumatic stress disorder.
If you’ve ever taken a medication and noticed the paperwork didn’t mention your specific condition, there’s a good chance you were receiving an off-label prescription.
Safety Compared to On-Label Use
Off-label use carries somewhat higher risk on average. One study found that off-label prescriptions were associated with a 44% higher likelihood of side effects in adults. In children, the risk of adverse events from off-label use may be up to 3.4 times higher than from on-label prescribing.
Those numbers come with an important caveat. When off-label prescribing is supported by strong scientific evidence, the rate of adverse events is similar to that of FDA-approved uses. The elevated risk comes primarily from off-label uses that lack solid research backing. In other words, the quality of evidence behind the prescription matters more than the label status itself.
Does Your Doctor Have to Tell You?
There is no legal requirement for physicians to disclose that a prescription is off-label. Courts have generally ruled that doctors don’t have a duty to explain a drug’s FDA regulatory status. Their obligation is to provide you with the clinical information you need to make a decision: what the drug does, what the risks are, and why they’re recommending it for your situation.
That said, the American Medical Association encourages shared decision-making, where patients are equal partners in treatment choices. You can always ask your doctor whether a medication is being prescribed for its approved use, and it’s reasonable to ask about the evidence supporting any off-label recommendation.
How Insurance Handles Off-Label Prescriptions
Insurance coverage for off-label use varies, and this is where patients most often run into friction. Many insurers will cover off-label prescriptions, but only when the use is considered “medically accepted” based on specific criteria. Medicare, for example, looks to recognized drug reference guides, such as the American Hospital Formulary Service Drug Information and the United States Pharmacopoeia Drug Information, to determine whether an off-label use qualifies for coverage.
For uses not listed in those references, insurers typically want to see evidence from clinical trials demonstrating safety and effectiveness. If your insurance denies coverage for an off-label prescription, your doctor can often submit supporting evidence or file an appeal. Some off-label uses are so well-established that denial is unlikely, while newer or less-studied uses may require more documentation.